A liver signaling pathway may explain why colorectal cancer weakens muscle and bone

Researchers at the University of Colorado Anschutz and Indiana University School of Medicine have identified a biological process that may help explain why colorectal cancer can cause severe muscle and bone loss, especially in its most advanced stages. The condition, known as cancer cachexia, can leave patients weak, make everyday activities more difficult and make it harder to tolerate cancer treatment.